Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details or page features.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing the previous v3.4.2 label.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision: v3.4.2 was added. The government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check82 days agoChange DetectedA government funding status notice was added and a new 2025 publication citation (KEEPSAKE 2) was added to Publications, while the older online-ahead-of-print citation was removed and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check89 days agoChange DetectedThe page adds a glossary display option and metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, and updates the No FEAR Act Data label and the revision to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.